Roth Puts A 'Buy' On Biotie...Firm Excited About 'Best In Class Treatment' For Parkinson's

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.